Replies to post #375580 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

Look, I don’t know what you’re trying to do here but I’m not conflating anything. Dr. Liau’s paper needs to be absolutely in line with how regulators will see it for approval. And it must answer as many of the questions as possible that the multitude or naysayers in the scientific community will protest with. If you don’t think that will happen I don’t think you know what you’re talking about. This is not pure scientific research for the purity of science, this is about approvals so patients can access the treatment, then about the business that will provide it all. Maybe I’m missing your point but if so you don’t appear to be articulating it well in my opinion

[skitahoe]

Foxhound,

While it's possible that Dr. Liau will speak to many of her peers over time, it should be noted that she doesn't work for the company. The term road show is normally associated with the company speaking to investors, usually through conferences held by brokerages and Institutions. If the company is going on a road show it probably is either to sell out an offering, or perhaps to build the share price to the level where a partnership, or buyout occurs.

I believe that Dr. Liau will be more open to speaking about DCVax-L once TLD is out, and she'll be the lead on any technical presentation as the lead clinician, but she won't go on a road show for DCVax alone. When she speaks, she speaks as one of the worlds greatest brain surgeon as well as the developer of the vaccine and other therapeutics for treating brain cancer.

Gary